Liraglutide in the Treatment of Type 1 Diabetes Mellitus
Latest Information Update: 08 Jan 2024
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 05 Apr 2016 Primary endpoint (Change in Mean Weekly Glucose Concentrations From Baseline at 12 Weeks) for 1.2 mg and 1.8 mg dose of Liraglutide has been met, according to results published in the Diabetes Care.
- 05 Apr 2016 Results analyzing efficacy of Liraglutide published in the Diabetes Care,
- 15 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.